Revenue: The sum of all revenue fields included for a company's operating activities.
Immuneering Corporation (IMRX) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-17.27M |
|
-- |
|
-- |
|
$19.00M |
|
$-19.00M |
|
$1.73M |
|
$-17.27M |
|
$-17.27M |
|
$-17.27M |
|
$-17.27M |
|
$-17.27M |
|
$-17.27M |
|
$-19.00M |
|
$-19.39M |
|
64.70M |
|
64.70M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$157.99M |
|
$0.88M |
|
$44.06M |
|
$202.06M |
|
$8.12M |
|
-- |
|
$3.20M |
|
$11.32M |
|
$190.74M |
|
$183.74M |
|
$190.74M |
|
64.70M |
|
| Cash Flow Statement Financials | |
$-34.93M |
|
$-52.59M |
|
$0.21M |
|
$128.65M |
|
$41.32M |
|
$-87.32M |
|
$3.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.05% |
|
-9.40% |
|
-8.55% |
|
-9.05% |
|
$2.95 |
|
$-0.54 |
|
$-0.54 |
|